Coronavirus Update: Imperial And Morningside Form Social Enterprise For COVID-19 Vaccine
Plus Updates From Daiichi And Shionogi
London university ready to launch clinical trials of vaccine based on self-amplifying RNA technology shortly.
You may also be interested in...
Concern and skepticism about Russia's rapid vaccine roll out. Meanwhile Japan is latest to reach deal with Pfizer/BioNTech.
Independent drug cost watchdog updates its twin pricing estimates for Gilead's drug - but dexamethasone could tip the balance again.
Anthony Fauci says a hasty emergency use authorization for a vaccine would be a mistake - and the FDA commissioner will not be drawn on timelines.